Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMedOpen access

Extracellular Vesicle-embedded alginate hydrogel patch for accelerated wound healing.

Jang WH., Bui VD., Duong VH., Shin S., Lee J., Ghosh T.

Laboratory Study on Chronic Wound, published in Mater Today Bio (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Mater Today Bio (2026)
Country
England
Reported sample size
—
Source database
PubMed
PMID
42293384
PMCID
PMC13264183
DOI
10.1016/j.mtbio.2026.103288
Citations
1

Abstract (original English)

The process of skin wound healing is markedly impaired by elevated levels of reactive oxygen species (ROS) and the persistent presence of pro-inflammatory macrophages in the injured tissue. To address these pathological challenges, we herein developed an alginate-based hydrogel patch (EGEV-Gel) engineered for the sustained release of human adipose stem cell-derived extracellular vesicles (hASC-EVs) and epigallocatechin gallate (EGCG). hASC-EVs were incorporated to promote tissue regeneration, while EGCG served as a potent ROS scavenger. In an in vitro wound healing model using the transwell insert system, EGEV-Gel demonstrated remarkable efficacy in suppressing M1 macrophage polarization, scavenging excessive ROS, and restoring the functional capacity of dermal fibroblasts and endothelial cells compromised by oxidative stress. When applied to the acute wound-induced mouse, EGEV-Gel significantly reduced the M1 macrophage population and the ROS level at 3 days post-treatment. Histological analysis of the skin layers further confirmed restoration of skin architecture, as demonstrated by the normalized thickness of key structural components, including the epidermis, collagen layer, and granulation tissue. These findings highlight the therapeutic potential of the hASC-EVs/EGCG-loaded hydrogel patch as a promising platform for promoting wound repair and modulating the inflammatory m

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research